In a report released today, Jo Walton from UBS maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price target of ...

StockNews.com upgraded shares of Novo Nordisk A/S (NYSE:NVO – Free Report) from a buy rating to a strong-buy rating in a report released on Thursday. A number of other analysts have also recently ...

In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price ...

An increasing share of the population is living in retirement for longer periods of time, offering "specific market ...

UBS analyst Joseph Spak reduced his first-quarter delivery target to 367,000 vehicles from 437,000. Whitecap Resources and Veren have agreed to combine their companies in $10.44 billion deal that will ...

Uncertainty around President Donald Trump’s tariff policies have sent the major averages on a roller-coaster ride and spurred ...

A sell-off across US markets has continued as investor sentiment soured amid growing fears that the world’s largest economy ...

The diabetes and weight loss drug market is heating up in 2025, with significant growth signs everywhere. According to a recent study from Research and Markets, industry growth is running at an ...

Rain sales on Big Tech stocks that overwhelm the Nasdaq but also infect the European lists. At Piazza Affari Buzzi and the ...

The European stock markets closed lower in Monday trading as The Stoxx Europe 600 fell 1.1%, Germany's DAX dropped 1.53%, the FTSE 100 in London was down 0.78%, France's CAC 40 declined 0.69%, and the ...

Wall Street’s stock markets plunged amid fears Donald Trump’s tariff trade war will hammer American growth. The tech-heavy ...